Indoco Remedies Profit & Loss Annual

Trade
BSE: 532612 | NSE: INDOCO | ISIN: INE873D01024 | Sector: Biotechnology & Drugs
321.90 +1.90 (0.59%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 1,817.291,668.611,540.751,241.53
Total Revenue 1,817.291,668.611,540.751,241.53
Costof Revenue Total 559.19589.93522.38407.02
Gross Profit 1,258.101,078.691,018.37834.51
Selling/ General/ Admin Expenses Total 361.93670.86582.36514.68
Research Development 971.60809.70746.42597.04
Depreciation/ Amortization 91.8770.6177.2173.13
Unusual Expense( Income) -11.530.001.750.00
Other Operating Expenses Total 554.7039.3033.5035.59
Total Operating Expense 1,653.321,451.671,291.841,090.12
Operating Income 163.97216.94248.92151.41
Interest Inc( Exp) Net- Non- Op Total -380.20-229.22-126.92-204.09
Other Net 9.850.030.861.24
Net Income Before Taxes 135.80192.79236.57132.00
Provisionfor Income Taxes 38.7950.5481.7738.95
Net Income After Taxes 97.01142.25154.8093.05
Minority Interest 1.460.000.000.00
Net Income Before Extra Items 98.47142.25154.8093.05
Net Income 98.47142.25154.8093.05
Income Availableto Com Excl Extra Ord 98.47142.25154.8093.05
Income Availableto Com Incl Extra Ord 98.47142.25154.8093.05
Diluted Net Income 98.47142.25154.8093.05
Diluted Weighted Average Shares 9.379.229.229.22
Diluted EPS Excluding Extra Ord Items 10.5115.4416.8010.10
DPS- Common Stock Primary Issue 1.502.251.501.50
Diluted Normalized EPS 9.6315.5416.9610.12
Gain( Loss)on Saleof Assets --12.62-5.11-2.43
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts